Therapeutic drug monitoring opportunities in cancer therapy
- 1 January 1997
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 74 (1) , 39-54
- https://doi.org/10.1016/s0163-7258(96)00201-x
Abstract
No abstract availableKeywords
This publication has 74 references indexed in Scilit:
- Population pharmacokinetics of carboplatin in children*Clinical Pharmacology & Therapeutics, 1996
- Prediction of Carboplatin Clearance From Standard Morphological and Biological Patient CharacteristicsJNCI Journal of the National Cancer Institute, 1995
- Evaluation of plasma 5-fluorouracil nucleoside levels in patients with metastatic breast cancer: relationships with toxicitiesCancer Chemotherapy and Pharmacology, 1995
- Individual dose adaptation of anticancer drugsEuropean Journal Of Cancer, 1994
- Intensive intravenous methotrexate and mercaptopurine treatment of higher-risk non-T, non-B acute lymphocytic leukemia: A Pediatric Oncology Group study.Journal of Clinical Oncology, 1994
- The optimisation of carboplatin dose in carboplatin, etoposide and bleomycin combination chemotherapy for good prognosis metastatic nonseminomatous germ cell tumours of the testisAnnals of Oncology, 1992
- Clinical pharmacokinetics of etoposide during 120 hours continuous infusions in solid tumoursBritish Journal of Cancer, 1990
- Carboplatin dosage: prospective evaluation of a simple formula based on renal function.Journal of Clinical Oncology, 1989
- Systemic clearance of methotrexate in the prognosis of acute lymphoblastic leukemia in childrenCancer, 1987
- The Clinical Pharmacology of Etoposide and TeniposideClinical Pharmacokinetics, 1987